224 related articles for article (PubMed ID: 36709100)
1. The bridging conundrum: perioperative management of direct oral anticoagulants for venous thromboembolism.
Berry J; Patell R; Zwicker JI
J Thromb Haemost; 2023 Apr; 21(4):780-786. PubMed ID: 36709100
[TBL] [Abstract][Full Text] [Related]
2. Thrombotic and bleeding outcomes following perioperative interruption of direct oral anticoagulants in patients with venous thromboembolic disease.
Shaw J; de Wit C; Le Gal G; Carrier M
J Thromb Haemost; 2017 May; 15(5):925-930. PubMed ID: 28296069
[TBL] [Abstract][Full Text] [Related]
3. Direct oral anticoagulant dose selection: Challenging cases.
Carlin S; Eikelboom JW
J Thromb Haemost; 2021 Nov; 19(11):2680-2686. PubMed ID: 34558172
[TBL] [Abstract][Full Text] [Related]
4. Direct oral anticoagulants in patients with venous thromboembolism and thrombophilia: a systematic review and meta-analysis.
Elsebaie MAT; van Es N; Langston A; Büller HR; Gaddh M
J Thromb Haemost; 2019 Apr; 17(4):645-656. PubMed ID: 30690830
[TBL] [Abstract][Full Text] [Related]
5. Expanding Indications of Nonvitamin K Oral Anticoagulants Beyond Nonvalvular Atrial Fibrillation and Venous Thromboembolism: A Review of Emerging Clinical Evidence.
Hajra A; Ujjawal A; Ghalib N; Chowdhury S; Biswas S; Balasubramanian P; Gupta R; Aronow WS
Curr Probl Cardiol; 2024 Jan; 49(1 Pt A):102017. PubMed ID: 37544618
[TBL] [Abstract][Full Text] [Related]
6. Vascular Disease Patient Information Page: Direct oral anticoagulants - 2020 update.
Vazquez SR
Vasc Med; 2020 Apr; 25(2):196-199. PubMed ID: 32031495
[No Abstract] [Full Text] [Related]
7. Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer.
Kahale LA; Hakoum MB; Tsolakian IG; Matar CF; Terrenato I; Sperati F; Barba M; Yosuico VE; Schünemann H; Akl EA
Cochrane Database Syst Rev; 2018 Jun; 6(6):CD006650. PubMed ID: 29920657
[TBL] [Abstract][Full Text] [Related]
8. Direct oral anticoagulants in patients with cancer.
Bossaer JB; Covert KL
Am J Health Syst Pharm; 2019 Jul; 76(14):1019-1027. PubMed ID: 31361880
[TBL] [Abstract][Full Text] [Related]
9. Which patients with unprovoked venous thromboembolism should receive extended anticoagulation with direct oral anticoagulants? A systematic review, network meta-analysis, and decision analysis.
Djulbegovic M; Lee AI; Chen K
J Eval Clin Pract; 2020 Feb; 26(1):7-17. PubMed ID: 31190408
[TBL] [Abstract][Full Text] [Related]
10. Insight into the perioperative management of direct oral anticoagulants: concerns and considerations.
Ibrahim A; Walsh LG; Algaali M; Satti Z; Kiernan TJ; Yan BP
Expert Opin Pharmacother; 2019 Mar; 20(4):465-472. PubMed ID: 30521411
[TBL] [Abstract][Full Text] [Related]
11. Direct Oral Anticoagulants: Laboratory Challenges and Antidotes.
Beyer-Westendorf J; Köhler C
Hamostaseologie; 2023 Feb; 43(1):37-43. PubMed ID: 36807818
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and Harms of Direct Oral Anticoagulants in the Elderly for Stroke Prevention in Atrial Fibrillation and Secondary Prevention of Venous Thromboembolism: Systematic Review and Meta-Analysis.
Sharma M; Cornelius VR; Patel JP; Davies JG; Molokhia M
Circulation; 2015 Jul; 132(3):194-204. PubMed ID: 25995317
[TBL] [Abstract][Full Text] [Related]
13. Managing the perioperative patient on direct oral anticoagulants.
Leitch J; van Vlymen J
Can J Anaesth; 2017 Jun; 64(6):656-672. PubMed ID: 28429198
[TBL] [Abstract][Full Text] [Related]
14. Edoxaban in venous thromboembolism and stroke prevention: an appraisal.
Proietti M; Lip GY
Vasc Health Risk Manag; 2016; 12():45-51. PubMed ID: 27013883
[TBL] [Abstract][Full Text] [Related]
15. Risk and Management of Bleeding Complications with Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Venous Thromboembolism: a Narrative Review.
Ballestri S; Romagnoli E; Arioli D; Coluccio V; Marrazzo A; Athanasiou A; Di Girolamo M; Cappi C; Marietta M; Capitelli M
Adv Ther; 2023 Jan; 40(1):41-66. PubMed ID: 36244055
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of direct oral anticoagulants in the pediatric population: a systematic review and a meta-analysis.
Giossi R; Menichelli D; D'Amico F; Idotta L; Cirino M; Scardoni L; Furlanetto C; Maggi M; Bernocchi O; Bosca F; Girlando L; Pignatelli P; Pani A; Pastori D; Tozzo A; Scaglione F; Fornasari D
J Thromb Haemost; 2023 Oct; 21(10):2784-2796. PubMed ID: 37481075
[TBL] [Abstract][Full Text] [Related]
17. Direct oral anticoagulants for treatment and prevention of venous thromboembolism in cancer patients.
Song AB; Rosovsky RP; Connors JM; Al-Samkari H
Vasc Health Risk Manag; 2019; 15():175-186. PubMed ID: 31417269
[TBL] [Abstract][Full Text] [Related]
18. Case-fatality of recurrent venous thromboembolism and major bleeding associated with aspirin, warfarin, and direct oral anticoagulants for secondary prevention.
Wu C; Alotaibi GS; Alsaleh K; Linkins LA; McMurtry MS
Thromb Res; 2015 Feb; 135(2):243-8. PubMed ID: 25488466
[TBL] [Abstract][Full Text] [Related]
19. A Comprehensive Overview of Direct Oral Anticoagulants for the Management of Venous Thromboembolism.
Comerota AJ; Ramacciotti E
Am J Med Sci; 2016 Jul; 352(1):92-106. PubMed ID: 27432042
[TBL] [Abstract][Full Text] [Related]
20. Direct oral anticoagulants versus standard anticoagulation in children treated for acute venous thromboembolism.
Chen J; Bi G; Wu F; Qin X
Pediatr Res; 2023 May; 93(6):1491-1498. PubMed ID: 36071237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
